A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

July 8, 2021

Study Completion Date

December 31, 2021

Conditions
Visceral ObesityUltrasound TherapyDyslipidemias
Interventions
DEVICE

focused power ultrasound treatment

Patients will be placed in the lateral decubitus position and receive treatment with sequential bilateral PRF ablation. Before the treatment, a professional sonographer will be responsible for the length, thickness, and width of PRF sac measurement and localisation, and utilise the ultrasonic diagnostic transducer to delineate the targeted region. The treatment will launch layer-by-layer. After confirming accurate localization of the treatment, layer-by-layer PRF ablation will be performed on the patients. The device generates and delivers a pattern of conic-shaped ultrasound energy to the PRF sac noninvasively. The treatment of FPU-mediated PRF ablation will be implemented once.

DEVICE

Sham treatment

Participants will receive the same procedure as those in the FPU treatment including PRF ultrasonic measurement and localization and focused ultrasound treatment parameters setting, except that no energy will be delivered to the PRF.

Trial Locations (1)

210029

JiangSu Province Hospital / The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT04223557 - A Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation | Biotech Hunter | Biotech Hunter